Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Greater Manchester, United Kingdom Clinical Trials

A listing of Greater Manchester, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

DermaRep Device in the Treatment of Venous Leg Ulcers

This is a First in Human clinical study on the safety and effectiveness of DermaRep wound contact dressing. Patients with venous leg ulcers will be treated with standard of care dressings and compression for 4 weeks to establish a baseline wound healing response. All patients will then be treated with ...

Phase N/A

2.76 miles

Learn More »

An Approach to "Move a Little & Often" With Health Conditions

There is a growing focus in research on the need to reduce sedentary behaviours. Studies have shown that independently of moderate to vigorous physical activity, the amount of time spent sedentary predicts poorer health outcomes. This means that in addition to exercising, it is important to reduce prolonged periods of ...

Phase N/A

3.18 miles

Learn More »

A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema.

Background Laser has been the treatment of choice for people with Diabetic Macular Oedema (DMO) since its beneficial effects were demonstrated by the ETDRS in 1985 [1]. In a recent appraisal [2], The National Institute of Health and Care Excellence (NICE) recommended the continued use of standard threshold laser to ...

Phase N/A

3.84 miles

Learn More »

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

Phase

7.12 miles

Learn More »

A Study to Investigate Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

CHF6297 is a potent and selective inhibitor of human MAP kinase p38 being developed as an anti-inflammatory agent for the treatment of inflammatory airways diseases. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat doses of CHF6297 as dry powder formulation ...

Phase

7.19 miles

Learn More »